Toku
Founded 2019 · 21 employees on LinkedIn · 18 known investors
Find your way into Toku
Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
Founders & leadership
Investors · 18
How we know: Icehouse Ventures's portfolio page · Not right? Tell us
How we know: Outset Ventures's portfolio page · Not right? Tell us
How we know: funding news · fortune.com · Not right? Tell us
How we know: funding news · prnewswire.com · Not right? Tell us
How we know: funding news · fortune.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · fortune.com · Not right? Tell us
How we know: funding news · fortune.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$57.3M disclosed across 2 of 3 rounds · 2023–2025
- $48MSeries AApr 2025 · 2 sourcesSource ↗
- $9.3MraisedApr 2024 · 2 sources
Gradient Ventures (lead), Clocktower, F-Prime Capital, Funders Club, Wollef, Y Combinator
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Toku do?
- Toku Eyes develops AI-driven solutions for eye health diagnostics and monitoring, bringing together medical expertise in endocrinology and ophthalmology with artificial intelligence capabilities.
- Who are Toku's investors?
- Toku's investors include Arc Angels, Icehouse Ventures, Outset Ventures, Blockchain Capital, F-Prime Capital, Funders Club Management, gmjp, Gradient Ventures and 6 more.
- How much funding has Toku raised?
- Toku has disclosed $57.3M raised across 2 of its 3 known rounds.







